Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Amgen Inc. (AMGN): A Bull Case Theory

We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Disruptive analytics. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc. (AMGN)'s share was trading at $291.16 as of Feb 14th. AMGN’s trailing and forward P/E were 38.51 and 14.27 respectively according to Yahoo Finance.

[caption id="attachment_1226536" align="aligncenter" width="768"] A biopharmaceutical team in a laboratory analyzing new compounds to develop therapeutics.[/caption]

Amgen (AMGN) remains undervalued at its current stock price of around $290, with a fair value estimate of...